We previously showed that CD40L and IL-4 increased HLA-E expression on the surface of primary CLL cells and inhibited NKG2A+ NK cell degranulation and IFNγ expression [23]. This evidence concerns the gene CD40LG and B-cell chronic lymphocytic leukemia.